Details of the Drug Reposition

General Information of This Drug (ID: DM5EUIY)

Drug Name	ROR1 CAR-specific Autologous T-Lymphocytes DM5EUIY
Drug Type	CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Chronic lymphocytic leukaemia	DISEXWC3	2A82.0	Phase 1	[1]
Acute lymphoblastic leukaemia	DIS87TGM	2A85	Phase 1	[1]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT02706392) Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies